WRAP Retail Offer for up to £500,000

Verici Dx Plc, (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, announces a retail offer via the Winterflood Retail Access Platform ("WRAP") to raise up to £500,000 (the "WRAP Retail Offer") through the issue of new ordinary shares of 0.1 pence each in the capital of the Company ("Ordinary Shares"). Under the WRAP Retail Offer up to 100,000,000 new Ordinary Shares (the "WRAP Retail Offer Shares") will be made available at a price of 0.5 pence per share (the "WRAP Issue Price").

In addition to the WRAP Retail Offer and as announced at 3:43pm on 21 July 2025, the Company has raised approximately £5.92 million ($7.96 million) through a Placing and Subscription of new Ordinary Shares at an issue price of 0.5 pence per Ordinary Share (the "Issue Price"). The Issue Price represents a discount of 42.9 per cent. to Verici Dx's closing mid-price on 18 July 2025 (being the last practicable day prior to the publication of the Proposed Fundraising announcement). The WRAP Issue Price is equal to the Issue Price.

The WRAP Retail Offer is conditional on the new Ordinary Shares being admitted to trading on AIM ("WRAP Admission"). It is anticipated that the WRAP Admission will become effective and that dealings in the new Ordinary Shares will commence at 8 a.m. on 30 July 2025.

WRAP Retail Offer

Therefore, the Company is making the WRAP Retail Offer open to eligible investors in the United Kingdom, being new or existing shareholders of Verici Dx, following release of this announcement and through certain financial intermediaries.

The Retail Offer is expected to close at 4:30pm on 28 July 2025. Eligible retail investors should note that financial intermediaries may have earlier closing times. The result of the Retail Offer is expected to be announced by the Company on or around 29 July 2025.

There is a minimum subscription of £100 per investor under the Retail Offer. The terms and conditions on which investors subscribe will be provided by the relevant financial intermediaries including relevant commission or fee charges.